AMD agrees to acquire Canadian AI chip startup Taalas

The transaction aims to boost AMD’s accelerator roadmap as AI workloads become increasingly specialised.

Image source: newsroom.amd.com
WT default author logo
Women's Tabloid News Desk

US semiconductor firm AMD has entered into a definitive agreement to acquire Taalas, a Canadian company specialising in AI inference silicon.

The deal is designed to enhance AMD’s long-term hardware plans as demand grows for specialised artificial intelligence workloads. AMD plans to combine Taalas’s specialised technology into its existing line of AI accelerators, creating system-level products alongside its AMD Instinct GPUs.

Founded in 2023, Toronto-based Taalas builds architecture that optimises inference dataflows. The firm’s engineering approach aims to bypass compute and memory bottlenecks that commonly affect general-purpose hardware when handling AI tasks.

The addition of Taalas will support AMD’s broader hardware and software lineup, which features AMD Helios rackscale solutions, AMD EPYC CPUs, AMD Instinct GPUs and the AMD ROCm software framework.

“AMD is building a full-stack AI platform that gives customers the flexibility to deploy the right compute solutions for every AI workload,” said Vamsi Boppana, senior vice president of the Artificial Intelligence Group at AMD. “Taalas’ technology and world-class engineering team strengthen our AI portfolio by delivering differentiated inference performance and efficiency.”

“We founded Taalas to rethink AI inference from the ground up by building the hardware around the model,” said Ljubisa Bajic, co-founder and CEO of Taalas. “Our Canada-based team has combined deep technical expertise with a willingness to challenge conventional approaches. Joining AMD will give us the scale, engineering resources and global reach to accelerate our innovation.”

The takeover builds on AMD’s established presence in Canada’s technology sector and marks a commitment to maintain regional engineering talent. The transaction remains subject to customary regulatory approvals and closing conditions before finalising.

Share:

Related Insights

Cross-Border Impact Ventures secures $58 million first close for second health technology fund

DarioHealth expands chronic care platform with new women’s health and sleep solutions

GE HealthCare launches new 3D breast ultrasound technology to improve supplemental screening

Defence Therapeutics appoints Dr Amie Phinney as President and CEO

UniCredit collaborates with Accenture and IBM on new banking technology platform

EU launches AI Gigafactories tender call to unlock 30 billion euros in computing investment

Entreprenista highlights 13 grant schemes available for female entrepreneurs

SBA launches $6 million modernisation competition for Women’s Business Centres